| Proposed Ticker: NTRL | 5140 Race Court | |
| Exchange: NASDAQ-National Market | Denver, Colorado 80216 | |
| Industry: Wholesale | (303) 297-9393 |
| All share information is proposed | ||||
| Type of Shares: | Common Shares | Filing Date: | 9/19/96 | |
| U.S. Shares Filed: | 1,700,000 | Filing Range: | $9.50 - $11.00 | |
| Non-U.S. Shares Filed: | 0 | Offering Amount: | $17,425,000 | |
| Primary Shares: | 1,475,000 | Expenses: | $600,000 | |
| Secondary Shares: | 225,000 | Shs Out After: | 3,352,472 | |
| Manager | Tier | Phone |
| Principal/Eppler, Guerrin & Turner, Inc., The | Lead Manager | (214) 880-9000 |
| Hanifen, Imhoff Inc. | Co-manager | (303) 296-2300 |
| Audited Income | Latest Unaudited Income | Prior Unaudited Income | Balance Sheet | ||
| 12/23/95 | 6/29/96 | 6/24/95 | 6/29/96 | ||
| Revenue: | $28.79 | $27.12 | $23.51 | Assets: | $5.86 |
| Net Income: | $0.77 | $0.24 | $0.28 | Liabilities: | $2.30 |
| EPS: | $0.42 | $0.12 | $0.16 | Equity: | $3.56 |
Note: Dollar amounts are in U.S. millions; Audited figures expressed as full year, unaudited figures are partial year | |||||
| Business Description |
| The company is the leading U.S. supplier and marketer of fresh, branded, natural beef products from cattle that have never received hormones and antibiotics. The company believes that it is the only company with national distribution that has an approved U.S. Department of Agriculture label describing its hormone and antibiotic free cattle raising practices. In the United States, most commodity beef comes from cattle which have been given antibiotics and implanted with hormones to accelerate growth and weight gain. In 1979, Mel Coleman, Sr., a fourth-generation Colorado rancher and the company's founder, pioneered the marketing of pure and natural beef, raised humanely and with respect for the environment. The company believes its products are not just a food, but a lifestyle. The company believes that there are a growing number of consumers demanding high quality, safe and pure products, and that they are willing to pay a premium for them. |
| Use of Proceeds |
| The proceeds from the proposed offering will be used for capital expenditures for new facilities, redemption of Series A Preferred Stock, sales and marketing programs, and general corporate purposes. |
©1996 IPO Data Systems, Inc. - All rights reserved.